---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Illumina

🌎 illumina.com

Illumina is a biotechnology research company headquartered in San Diego, CA, focused on applying innovative technologies and revolutionary assays to the analysis of genetic variation and function. The company aims to enable personalized medicine through its advanced sequencing and array technologies, which support life science research, translational and consumer genomics, and molecular diagnostics. Illumina offers a broad range of products and services for genomic analysis, including DNA, RNA, and protein analysis tools, and emphasizes collaborative interactions and customer needs.

---

Illumina News & Insights as of Oct 11, 2024

• Illumina received FDA approval for its TruSight Oncology Comprehensive test, which analyzes over 500 genes to help identify patients eligible for Bayer’s Vitrakvi and Eli Lilly’s Retevmo cancer treatments.
• Illumina recently acquired Partek Flow multiomics analysis software and Fluent Biosciences single-cell prep technology.
• Illumina's TruSight Oncology 500 DNA/RNA, RNA Prep with Enrichment, and DNA PCR-Free Prep are now part of the Biomek NGeniuS Next Generation Library Preparation System's portfolio.
• Illumina launched the MiSeq i100 Series with XLEAP Chemistry and RT Reagents, featuring two new benchtop sequencing systems, MiSeq i100 and MiSeq i100 Plus, on October 10.
• Illumina is adding new benchtop DNA sequencing instruments that use the technology and chemistry of its high-end machines.

---

Sign up to receive regular updates

If you liked this report, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.